Pharmacyclics' Gadolite approved in UK:
This article was originally published in Clinica
Pharmacyclics' Gadolite MRI contrast agent has been approved by the UK Medicines Control Agency. Gadolite is administered orally in the diagnosis of pelvic and abdominal disorders (see p 9). Pharmacyclics, based in Sunnyvale, California, submitted a new drug application for Gadolite to the FDA in September.